Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 23-Dec-14 4:30 PM View:  | Glycomimetics Inc (GLYC) | 22-Dec-14 | Market Sale | 10,659 | $8.44 | $89,912.90 | (2%) 515.34K to 504.68K | 69% |
| 23-Dec-14 4:30 PM View: | Glycomimetics Inc (GLYC) | 19-Dec-14 | Market Sale | 10,598 | $8.61 | $91,277.40 | (2%) 525.94K to 515.34K | 69% |
| 17-Dec-14 6:10 PM View: | Glycomimetics Inc (GLYC) | 17-Dec-14 | Market Sale | 5,121 | $8.97 | $45,935.40 | (< 1%) 1.52M to 1.52M | 70% |
| 17-Dec-14 6:10 PM View: | Glycomimetics Inc (GLYC) | 15-Dec-14 | Market Sale | 1,604 | $8.98 | $14,403.90 | (< 1%) 1.53M to 1.52M | 70% |
| 17-Dec-14 6:10 PM View: | Glycomimetics Inc (GLYC) | 15-Dec-14 | Exercise (in-the money or at-the-money) | 43,628 | $0.33 | $14,397.20 | 3% 1.48M to 1.53M | |
| 13-Jun-14 4:01 PM View: | Glycomimetics Inc (GLYC) | 13-Jun-14 | Market Purchase | 5,000 | $6.21 | $31,050.00 | 1% 484.04K to 489.04K | (57%) |
| 13-Jun-14 4:01 PM View: | Glycomimetics Inc (GLYC) | 12-Jun-14 | Market Purchase | 6,000 | $6.54 | $39,240.00 | 1% 478.04K to 484.04K | (59%) |
| 03-Apr-14 4:38 PM View: | Glycomimetics Inc (GLYC) | 03-Apr-14 | Option Exercise | 1,562 | $1.12 | $1,749.44 | < 1% 476.48K to 478.04K | |
| 15-Jan-14 4:59 PM View: | Glycomimetics Inc (GLYC) | 15-Jan-14 | Conversion | 349,515 | -- | -- | 275% 126.96K to 476.48K | |
| 13-Jan-12 6:49 PM View: | Inhibitex Inc. (INHX) | 11-Jan-12 | Option Exercise | 18,000 | $8.79 | $158,220.00 | 14% 127.35K to 145.35K | |
| 04-Nov-11 5:09 PM View: | Inhibitex Inc. (INHX) | 02-Nov-11 | Option Exercise | 36,000 | $3.88 | $139,680.00 | 39% 91.35K to 127.35K | 2% |
| 01-Mar-11 9:07 PM View: | Genoptix, Inc. (GXDX) | 25-Feb-11 | Disposition (change in control) | 4,514 | $25.00 | $112,850.00 | (68%) 6.6K to 2.08K | < 1% |
| 03-Jun-10 8:18 PM View: | Genoptix, Inc. (GXDX) | 01-Jun-10 | Grant | 2,500 | -- | -- | 61% 4.1K to 6.6K | |
| 18-Mar-10 2:03 PM View: | Genoptix, Inc. (GXDX) | 16-Mar-10 | Market Sale | 5,000 | $35.50 | $177,485.00 | (55%) 9.1K to 4.1K | (1%) |
| 06-Jul-09 7:03 PM View: | Genoptix, Inc. (GXDX) | 01-Jul-09 | Market Sale (Planned) | 7,419 | $31.91 | $236,770.00 | (45%) 16.52K to 9.1K | 13% |
| 04-Jun-09 8:22 PM View: | Genoptix, Inc. (GXDX) | 02-Jun-09 | Grant | 2,500 | -- | -- | 18% 14.02K to 16.52K | |
| 18-Dec-08 5:22 PM View: | Genoptix, Inc. (GXDX) | 16-Dec-08 | Option Exercise | 1,181 | $30.76 | $36,327.60 | 9% 12.84K to 14.02K | (14%) |
| 04-Nov-08 9:29 AM View: | Atherogenics Inc. (AGIX) | 31-Oct-08 | Market Sale | 100,000 | $0.06 | $5,900.00 | (100%) 100.0K to 0 | 13% |
| 18-Aug-08 4:49 PM View: | Genoptix, Inc. (GXDX) | 14-Aug-08 | Market Sale | 618,646 | $37.00 | $22,889,900.00 | (98%) 631.48K to 12.84K | 28% |
| 07-Jul-08 4:40 PM View: | Inhibitex Inc. (INHX) | 03-Jul-08 | Payment of Exercise | 30,796 | $0.66 | $20,325.40 | (19%) 166.31K to 135.51K | 29% |
| 19-Jun-08 6:55 PM View: | Genoptix, Inc. (GXDX) | 17-Jun-08 | Grant | 7,500 | -- | -- | < 1% 1.86M to 1.86M | |
| 11-Mar-08 5:27 PM View: | Genoptix, Inc. (GXDX) | 10-Mar-08 | Market Sale | 66,705 | $25.50 | $1,700,980.00 | (3%) 1.92M to 1.86M | (4%) |
| 06-Mar-08 7:22 PM View: | Genoptix, Inc. (GXDX) | 05-Mar-08 | Market Sale Duplicate | 397,034 | $25.50 | $10,124,400.00 | (17%) 2.32M to 1.92M | (4%) |
| 02-Jan-08 2:55 PM View: | Inhibitex Inc. (INHX) | 31-Dec-07 | Acquisition (other) | 163 | $0.78 | $127.14 | < 1% 2.93M to 2.93M | (40%) |
| 02-Jan-08 2:55 PM View: | Inhibitex Inc. (INHX) | 31-Dec-07 | Disposition (other) | 163 | $0.78 | $127.14 | (< 1%) 2.93M to 2.93M | 40% |
| 07-Dec-07 4:25 PM View: | Atherogenics Inc. (AGIX) | 06-Dec-07 | Market Sale | 30,000 | $0.48 | $14,539.40 | (23%) 130.0K to 100.0K | (69%) |
| 05-Nov-07 8:56 PM View: | Genoptix, Inc. (GXDX) | 02-Nov-07 | Conversion | 2,556,260 | -- | -- | 36% 7.02M to 9.57M | |
| 05-Nov-07 8:56 PM View: | Genoptix, Inc. (GXDX) | 02-Nov-07 | Sale | 236,629 | $17.00 | $4,022,690.00 | (2%) 9.57M to 9.34M | |
| 05-Jul-06 5:17 PM View: | Inhibitex Inc. (INHX) | 03-Jul-06 | Grant | 84,986 | $1.76 | $150,000.00 | 340% 25.0K to 109.99K | (73%) |
| 22-May-06 3:58 PM View: | Inhibitex Inc. (INHX) | 18-May-06 | Grant | 25,000 | $1.95 | $48,625.00 | 100% 0 to 25.0K | (76%) |
| 12-Nov-04 11:04 AM View: | Inhibitex Inc. (INHX) | 10-Nov-04 | Private Purchase | 115,300 | $7.34 | $846,302.00 | 4% 2.77M to 2.88M | |
| 14-Jun-04 10:31 AM View: | Inhibitex Inc. (INHX) | 09-Jun-04 | Conversion | 2,652,280 | -- | -- | 2303% 115.15K to 2.77M | |
| 07-Jun-04 2:55 PM View: | Inhibitex Inc. (INHX) | 03-Jun-04 | Purchase | 103,000 | $7.00 | $721,000.00 | 847% 12.16K to 115.16K | (92%) |
| 24-Feb-04 10:00 PM View: | Atherogenics Inc. (AGIX) | 24-Feb-04 | Option Exercise | 80,000 | $6.10 | $488,000.00 | 160% 50.0K to 130.0K | |
| 11-Feb-04 10:00 PM View: | Atherogenics Inc. (AGIX) | 10-Feb-04 | Market Sale | 5,000 | $22.06 | $110,297.00 | (9%) 55.0K to 50.0K | 96% |
| 11-Feb-04 10:00 PM View: | Atherogenics Inc. (AGIX) | 09-Feb-04 | Market Sale | 20,000 | $22.00 | $440,002.00 | (27%) 75.0K to 55.0K | 96% |
| 16-Jan-04 10:00 PM View: | Atherogenics Inc. (AGIX) | 16-Jan-04 | Market Sale | 5,000 | $18.05 | $90,250.00 | (6%) 80.0K to 75.0K | 95% |
| 16-Jan-04 10:00 PM View: | Atherogenics Inc. (AGIX) | 15-Jan-04 | Market Sale | 20,000 | $18.00 | $360,030.00 | (20%) 100.0K to 80.0K | 95% |
| 16-Dec-03 10:00 PM View: | Atherogenics Inc. (AGIX) | 12-Dec-03 | Market Sale | 951 | $13.75 | $13,076.20 | (< 1%) 100.95K to 100.0K | 94% |
| 20-Nov-03 10:00 PM View: | Atherogenics Inc. (AGIX) | 18-Nov-03 | Market Sale | 26,951 | $15.21 | $409,909.00 | (21%) 126.95K to 100.0K | 95% |
| 14-Oct-03 10:00 PM View: | Atherogenics Inc. (AGIX) | 10-Oct-03 | Market Sale | 20,000 | $16.81 | $336,124.00 | (14%) 146.95K to 126.95K | 95% |
| 10-Oct-03 10:00 PM View: | Atherogenics Inc. (AGIX) | 09-Oct-03 | Market Sale | 20,000 | $17.54 | $350,800.00 | (12%) 166.95K to 146.95K | 95% |
| 10-Oct-03 10:00 PM View: | Atherogenics Inc. (AGIX) | 08-Oct-03 | Market Sale | 20,000 | $17.60 | $352,066.00 | (11%) 186.95K to 166.95K | 95% |
| 08-Oct-03 10:00 PM View: | Atherogenics Inc. (AGIX) | 07-Oct-03 | Market Sale | 20,000 | $17.12 | $342,460.00 | (10%) 206.95K to 186.95K | 95% |
| 08-Oct-03 10:00 PM View: | Atherogenics Inc. (AGIX) | 06-Oct-03 | Market Sale | 20,000 | $17.27 | $345,400.00 | (9%) 226.95K to 206.95K | 95% |